Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
The trial will be conducted across eight sites in Maharashtra
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
The company has to approach the DCGI for approval to commence the trials
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
AstraZeneca, Sinopharm and Moderna were part of the study
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
Subscribe To Our Newsletter & Stay Updated
